SEBI Consultation Paper on Streamlining the process and reduction in timelines of Bonus Issue (enabling T+2 trading of shares post record date where T being record date)
It has been decided to reduce the time taken for credit of bonus shares and trading of such shares, from the record date of the Bonus Issue under SEBI (ICDR) Regulations, 2018.
SEBI Consultation Paper on proposed amendments to the SEBI (Prohibition of Insider Trading) Regulations, 2015 to redefine ‘connected person’
The comments along with rationale may be submitted by any of the following modes latest by August 18, 2024 online.
SEBI Consultation Paper on investment by Foreign Investors through Segregated Portfolios/ P-notes/ Offshore Derivative Instruments
The comments/ suggestions should be submitted latest by August 27, 2024.
SEBI Consultation Paper on draft circular for Reporting by Foreign Venture Capital Investors
The circular seeks to amend format for quarterly report on venture capital activity to be submitted by FVCIs. FVCI shall submit the quarterly report irrespective of the fact that any investment is made or not during the quarter.
New Updates to Chhattisgarh Municipal Accounts Rules: What You Need to Know
Previously, the Chief Municipal Officer (CMO) had to submit documents to a competent authority for a payment order. Now, the rules have changed. The CMO will have the authority to issue payment orders directly on each bill or voucher
India Exempts Local Clinical Trials For New Foreign Drugs
The Indian government has announced a streamlined approval process for certain categories of new drugs recognizing approvals from key global regulatory authorities. CDSCO has specified a waiver from local clinical trials for USA, UK, Japan, Australia, Canada, and the European Union (EU).
CDSCO Urges Manufacturers To Implement New Drug Manufacturing Rules
The guidelines outline several key principles to be adhered to by pharmaceutical manufacturers, focusing on pharmaceutical quality systems, quality risk management, sanitation and hygiene, qualification and validation, complaints and adverse reactions, product recalls, and change control. The CDSCO has also advocated for manufacturers to comply particularly with WHO good manufacturing practices for sterile pharmaceutical products.
CERC Finalizes Tariff for Renewable Energy Projects From July 1, 2024 To March 31, 2025
The Commission has maintained the proposed bagasse fuel prices for the first year of the control period for bagasse-based cogeneration plants. Additionally, the final levellized generic tariff for Renewable Energy (RE) projects has been determined for various projects and for different states of the country.
New Regulations to Ensure Power Grid Stability
The primary goal of these regulations is to discourage deviations from the power schedule, which can lead to grid instability. To achieve this, a commercial mechanism will be implemented to penalize such deviations. All grid-connected entities, including power generators, distributors, and traders, will be subject to these new rules.